Transforming science into outstanding service through our flexible service models
by Timothy S. Oostdyk, Ph.D., President, Eurofins Lancaster Laboratories; Sr. Vice President, Eurofins BioPharma Product Testing Group
Our team continues to work hard every day to provide you with the world’s most comprehensive range of GMP product testing services, harmonized and robust quality systems and a market leading LIMS. But ultimately it is the collaboration with our clients and use of our flexible service models that have been the driving force behind our successful long-term client partnerships. It is one thing to have enviable facilities and capabilities, yet quite another to house some of the industry’s brightest scientists and project managers working to transform our scientific capabilities and service models into a truly compelling and strategic service.
Simply put, our primary goal is to engage with our clients to enable them to most effectively maximize their research and manufacturing expenditures. And we have found that the most effective way to do this is with highly evolved and flexible service models, which include our fee-for-service (FFS), managed hours, full time equivalent (FTE), and award-winning Professional Scientific ServicesSM (PSS).
Clients outsourcing activities and business needs can vary greatly and change rapidly, depending on phase of development, manufacturing strategy, country, regulatory requirements, timelines and budgets. Therefore many of our clients opt for the use of multiple service models, depending on their immediate needs and insourcing/outsourcing strategies.
There are many examples of this that I could give you. One scenario that we have seen numerous times in multiple countries involves the commissioning of a new facility or validation of a new process. In this situation our in-house PSS teams support a variety of validation and QC activities, while our laboratory facilities provide fee for service testing expertise and capacity for a variety of supporting activities. This can be highly cost effective while providing significant talent to help manage the multitude of challenges that occur with facility/process implementation.
Another common example is support of our clients who plan to market products in multiple regions under different regulatory authorities, and therefore engage our Eurofins Biopharma Product Testing laboratories in both the US and EU. We have found that dedicated FTE teams at our labs in both the US and EU have been highly effective, and allow us to perform simultaneous method implementation. This is accomplished under protocol through a highly-coordinated, covalidation activity between the FTE teams.
In both these examples, we also support these clients’ other outsourcing needs, such as raw materials testing, under a traditional FFS contract. The result of the multiple service models and global lab presence is an efficient, flexible, cost effective, and harmonized experience.
The bottom line is that we know that everyone in our industry today has significant timeline and cost challenges. So we have built our business to offer the most comprehensive range of testing services available in the industry, along with the most strategic and flexible service models. And to me there is nothing more satisfying than when I see this strategy delivering real value to our clients, and when I see us playing a key role in helping you bring life improving therapies to patients everywhere.
We thank you for your business, and look forward to serving you.
